Hedge Fund - Knoll Capital Management
Keryx Biopharmaceuticals Inc (KERX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2017 - Q4 (2017-12-31) | $0 | 0% | 0 | $5.51 |
| 2 | 2017 - Q3 (2017-09-30) | $1,420,000 | 1.21% | 200,000 | $7.19 |
| 3 | 2017 - Q2 (2017-06-30) | $1,446,000 | 1.91% | 200,000 | $6.25 |
| 4 | 2017 - Q1 (2017-03-31) | $1,232,000 | 1.85% | 200,000 | $5.48 |
| 5 | 2016 - Q4 (2016-12-31) | $1,172,000 | 2.05% | 200,000 | $5.46 |
| 6 | 2016 - Q3 (2016-09-30) | $1,030,000 | 1.8% | 200,000 | $5.39 |
| 7 | 2016 - Q2 (2016-06-30) | $1,324,000 | 0.42% | 200,000 | $5.59 |
| 8 | 2016 - Q1 (2016-03-31) | $934,000 | 0.37% | 200,000 | $3.99 |
| 9 | 2015 - Q4 (2015-12-31) | $1,010,000 | 0.37% | 200,000 | $4.75 |
| 10 | 2015 - Q3 (2015-09-30) | $704,000 | 0.29% | 200,000 | $6.70 |
| 11 | 2015 - Q2 (2015-06-30) | $1,996,000 | 0.64% | 200,000 | $10.72 |
| 12 | 2015 - Q1 (2015-03-31) | $2,546,000 | 0.74% | 200,000 | $12.86 |
| 13 | 2014 - Q4 (2014-12-31) | $2,830,000 | 1.11% | 200,000 | $15.50 |
| 14 | 2014 - Q3 (2014-09-30) | $2,750,000 | 1.08% | 200,000 | $15.31 |
| 15 | 2014 - Q2 (2014-06-30) | $3,076,000 | 1.37% | 200,000 | $14.17 |
| 16 | 2014 - Q1 (2014-03-31) | $3,408,000 | 1.76% | 200,000 | $15.09 |
| 17 | 2013 - Q4 (2013-12-31) | $2,592,000 | 1.3% | 200,000 | $11.94 |
| 18 | 2013 - Q3 (2013-09-30) | $1,009,000 | 0.53% | 100,000 | $8.90 |
| 19 | 2013 - Q2 (2013-06-30) | $747,000 | 0.51% | 100,000 | $7.81 |
The displayed share prices are average quarterly stock market prices.